<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">(.–.) </span>
   <span class="font27">metabolic </span>
   <span class="font19">adipose </span>
   <span class="font19">syndrome </span>
   <span class="font19">adipokines </span>
   <span class="font18">patients </span>
   <span class="font18">concentrations </span>
   <span class="font17">tissue </span>
   <span class="font17">adipokine </span>
   <span class="font16">relation </span>
   <span class="font16">plasma </span>
   <span class="font15">. ± . </span>
   <span class="font15">adiposity </span>
   <span class="font15">vascular </span>
   <span class="font14">higher </span>
   <span class="font14">{border-style </span>
   <span class="font14">related </span>
   <span class="font14">px;} </span>
   <span class="font14">risk </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">disease </span>
   <span class="font14">insulin </span>
   <span class="font13">VAT </span>
   <span class="font13">adiponectin </span>
   <span class="font13">growth </span>
   <span class="font13">syndrome. </span>
   <span class="font13">visceral </span>
   <span class="font13">(%) </span>
   <span class="font13">leptin </span>
   <span class="font13">study </span>
   <span class="font13"> ±  </span>
   <span class="font12">cardiovascular </span>
   <span class="font12">measurements </span>
   <span class="font12">subcutaneous </span>
   <span class="font12">(OR </span>
   <span class="font12">adjusted </span>
   <span class="font12">body </span>
   <span class="font12">disease. </span>
   <span class="font12">fat </span>
   <span class="font12">presence </span>
   <span class="font12">profile </span>
   <span class="font12">age </span>
   <span class="font12">lower </span>
   <span class="font12">model </span>
   <span class="font12">relations </span>
   <span class="font12">resistin </span>
   <span class="font12">(–) </span>
   <span class="font12">.–.) </span>
   <span class="font12">Clin </span>
   <span class="font12">[Internet]; </span>
   <span class="font12">clinically </span>
   <span class="font12">different </span>
   <span class="font12">factor; </span>
   <span class="font12">general </span>
   <span class="font12">healthy </span>
   <span class="font12">hepatic </span>
   <span class="font12">serum </span>
   <span class="font12">type </span>
   <span class="font11">(accessed </span>
   <span class="font11">July </span>
   <span class="font11">Table </span>
   <span class="font11">cohort </span>
   <span class="font11">factors </span>
   <span class="font11">increase </span>
   <span class="font11">manifest </span>
   <span class="font11">measured </span>
   <span class="font11">obese </span>
   <span class="font11">protein </span>
   <span class="font11">px; </span>
   <span class="font11">resistance </span>
   <span class="font11">syndrome, </span>
   <span class="font11">{font-family </span>
   <span class="font11">BMI </span>
   <span class="font11">Cardiol; </span>
   <span class="font11">HGF </span>
   <span class="font11">abdominal </span>
   <span class="font11">amyloid </span>
   <span class="font11">artery </span>
   <span class="font11">associated </span>
   <span class="font11">association </span>
   <span class="font11">chemerin </span>
   <span class="font11">font-size </span>
   <span class="font11">interaction </span>
   <span class="font11">levels </span>
   <span class="font11">(n = ) </span>
   <span class="font11">Department </span>
   <span class="font11">Endocrinol </span>
   <span class="font11">Metab </span>
   <span class="font11">Results </span>
   <span class="font11">activator </span>
   <span class="font11">adipokines, </span>
   <span class="font11">adjustment </span>
   <span class="font11">concentration </span>
   <span class="font11">development </span>
   <span class="font11">diabetes </span>
   <span class="font11">double; </span>
   <span class="font11">dysfunction </span>
   <span class="font11">factor </span>
   <span class="font11">inhibitory </span>
   <span class="font11">mass </span>
   <span class="font11">metabolically </span>
   <span class="font11">migration </span>
   <span class="font11">nerve </span>
   <span class="font11">obesity </span>
   <span class="font11">performed </span>
   <span class="font11">plasminogen </span>
   <span class="font11">recent </span>
   <span class="font11">regression </span>
   <span class="font11">seen </span>
   <span class="font11">waist </span>
   <span class="font11">.–.). </span>
   <span class="font11">Also, </span>
   <span class="font11">Relation </span>
   <span class="font11">SAA </span>
   <span class="font11">Supplementary </span>
   <span class="font11">absence </span>
   <span class="font11">adipokines. </span>
   <span class="font11">adiposity, </span>
   <span class="font11">adipsin </span>
   <span class="font11">blood </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">chemerin, </span>
   <span class="font11">chemoattractant </span>
   <span class="font11">circumference </span>
   <span class="font11">coronary </span>
   <span class="font11">current </span>
   <span class="font11">data </span>
   <span class="font11">defined </span>
   <span class="font11">disease, </span>
   <span class="font11">distribution </span>
   <span class="font11">factor, </span>
   <span class="font11">gender </span>
   <span class="font11">gender. </span>
   <span class="font11">glucose </span>
   <span class="font11">history </span>
   <span class="font11">lipid-lowering </span>
   <span class="font11">measurements. </span>
   <span class="font11">monocyte </span>
   <span class="font11">negative </span>
   <span class="font11">odds </span>
   <span class="font11">potential </span>
   <span class="font11">presented </span>
   <span class="font11">pressure </span>
   <span class="font11">pro-inflammatory </span>
   <span class="font11">quantity </span>
   <span class="font11">resistin, </span>
   <span class="font11">results. </span>
   <span class="font11">shown </span>
   <span class="font11">single </span>
   <span class="font11">solid; </span>
   <span class="font11">ultrasound </span>
   <span class="font11">weight </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">(.–. cm) </span>
   <span class="font10">(CIs) </span>
   <span class="font10">(n = ), </span>
   <span class="font10">. mmol/L </span>
   <span class="font10">ATD </span>
   <span class="font10">BMI, </span>
   <span class="font10">C-reactive </span>
   <span class="font10">CI) </span>
   <span class="font10">Care; </span>
   <span class="font10">Cholesterol </span>
   <span class="font10">Circulation; </span>
   <span class="font10">Data </span>
   <span class="font10">Diabetes </span>
   <span class="font10">Eur </span>
   <span class="font10">Int </span>
   <span class="font10">Medical </span>
   <span class="font10">Metab; </span>
   <span class="font10">Prev </span>
   <span class="font10">adjustments </span>
   <span class="font10">analysis </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">atherosclerosis </span>
   <span class="font10">atherosclerotic </span>
   <span class="font10">bold </span>
   <span class="font10">calculated </span>
   <span class="font10">causal </span>
   <span class="font10">characteristics </span>
   <span class="font10">clinical </span>
   <span class="font10">confidence </span>
   <span class="font10">courier; </span>
   <span class="font10">effects </span>
   <span class="font10">em; </span>
   <span class="font10">function </span>
   <span class="font10">greater </span>
   <span class="font10">high-sensitivity </span>
   <span class="font10">independent </span>
   <span class="font10">index </span>
   <span class="font10">individual </span>
   <span class="font10">inflammatory </span>
   <span class="font10">influence </span>
   <span class="font10">inhibitor </span>
   <span class="font10">intervals </span>
   <span class="font10">leading </span>
   <span class="font10">leptin, </span>
   <span class="font10">low-grade </span>
   <span class="font10">men </span>
   <span class="font10">population </span>
   <span class="font10">pt;} </span>
   <span class="font10">strongest </span>
   <span class="font10">tissue. </span>
   <span class="font10">using </span>
   <span class="font10">various </span>
   <span class="font10">–.; </span>
  </p>
 </body>
</html>
